Man Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Sell
309,659
-51,836
-14% -$3.02M 0.04% 558
2025
Q4
$21.5M Sell
361,495
-1,131,884
-76% -$61.6M 0.04% 489
2025
Q3
$80.9M Buy
1,493,379
+16,457
+1% +$941K 0.16% 161
2025
Q2
$81.2M Buy
1,476,922
+672,628
+84% +$39.6M 0.18% 143
2025
Q1
$56.9M Buy
804,294
+301,659
+60% +$20.3M 0.17% 163
2024
Q4
$33M Sell
502,635
-113,443
-18% -$7.6M 0.1% 269
2024
Q3
$43.3M Buy
616,078
+485,670
+372% +$40.6M 0.12% 229
2024
Q2
$10.7M Buy
130,408
+45,362
+53% +$3.78M 0.03% 678
2024
Q1
$7.43M Buy
85,046
+20,703
+32% +$1.85M 0.02% 824
2023
Q4
$6.2M Buy
+64,343
New +$5.69M 0.02% 858
2023
Q3
Sell
-279,334
Closed -$24.9M 698
2023
Q2
$24.2M Buy
+279,334
New +$26.3M 0.08% 329
2023
Q1
Sell
-663,969
Closed -$68.8M 81
2022
Q4
$68.7M Buy
663,969
+115,421
+21% +$10.8M 0.25% 88
2022
Q3
$46.5M Buy
+548,548
New +$48.8M 0.22% 110
2022
Q2
Sell
-64,777
Closed -$5.16M 407
2022
Q1
$5M Buy
+64,777
New +$5.42M 0.02% 898
2021
Q4
Sell
-10,764
Closed -$832K 1959
2021
Q3
$832K Sell
10,764
-5,515
-34% -$435K ﹤0.01% 1388
2021
Q2
$1.36M Sell
16,279
-47,504
-74% -$3.77M ﹤0.01% 1320
2021
Q1
$4.82M Buy
63,783
+17,868
+39% +$1.46M 0.02% 707
2020
Q4
$4.03M Buy
45,915
+656
+1% +$52K 0.02% 921
2020
Q3
$3.44M Sell
45,259
-48,177
-52% -$4.87M 0.01% 992
2020
Q2
$11.5M Buy
93,436
+64,813
+226% +$6.44M 0.06% 317
2020
Q1
$2.42M Sell
28,623
-13,677
-32% -$1.18M 0.02% 811
2019
Q4
$3.58M Buy
42,300
+3,460
+9% +$261K 0.01% 1118
2019
Q3
$2.62M Buy
38,840
+1,522
+4% +$117K 0.01% 1156
2019
Q2
$3.2M Sell
37,318
-6,037
-14% -$516K 0.01% 1137
2019
Q1
$3.85M Sell
43,355
-31,711
-42% -$2.94M 0.01% 1049
2018
Q4
$6.39M Sell
75,066
-14,116
-16% -$1.34M 0.03% 641
2018
Q3
$8.65M Buy
89,182
+63,109
+242% +$6.3M 0.03% 702
2018
Q2
$2.46M Sell
26,073
-91,113
-78% -$7.98M 0.01% 1277
2018
Q1
$9.5M Buy
+117,186
New +$10.1M 0.04% 521

Other funds holding BMRN